Kayıkçıoğlu, E. and Onder, A. H. . (2022) “The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors”, Chronicles of Precision Medical Researchers, 3(3). doi: 10.5281/zenodo.7195780.